🛡️ We’re checking your connection to prevent automated abuse Help us keep things secure—confirm you’re not a robot to proceed ⏳ Verifying your browser… Why am I seeing this? Having problems? Contact support ✓ Verification Complete This page will redirect in a moment… Read MoreContinue Reading
🛡️ We’re checking your connection to prevent automated abuse ⏳ Verifying your browser… Why am I seeing this verification? Having problems? Contact support ✓ Verification Complete This page will redirect in a moment… Read MoreContinue Reading
🛡️ We’re checking your connection to prevent automated abuse ⏳ Verifying your browser… Why am I seeing this verification? Having problems? Contact support ✓ Verification Complete This page will redirect in a moment… Read MoreContinue Reading
Published: March 06, 2026, 12:05 am According to a heavily redacted report just released, the FDA issued an import alert requiring border holds on an unnamed produce item linked to a deadly Listeria outbreak that stretched from April 2024 through at least June 2025. The Food and Drug Administration investigatedContinue Reading
🛡️ We’re checking your connection to prevent automated abuse ⏳ Verifying your browser… Why am I seeing this verification? Having problems? Contact support ✓ Verification Complete This page will redirect in a moment… Read MoreContinue Reading
🛡️ We’re checking your connection to prevent automated abuse ⏳ Verifying your browser… Why am I seeing this verification? Having problems? Contact support ✓ Verification Complete This page will redirect in a moment… Read MoreContinue Reading
🛡️ We’re checking your connection to prevent automated abuse ⏳ Verifying your browser… Why am I seeing this verification? Having problems? Contact support ✓ Verification Complete This page will redirect in a moment… Read MoreContinue Reading
🛡️ We’re checking your connection to prevent automated abuse ⏳ Verifying your browser… Why am I seeing this verification? Having problems? Contact support ✓ Verification Complete This page will redirect in a moment… Read MoreContinue Reading
— Median overall survival with olaparib plus abiraterone reached 68 months in mid-stage trial February 27, 2026 • 3 min read SAN FRANCISCO — The first-line combination of olaparib (Lynparza) plus abiraterone (Zytiga) led to a significant overall survival (OS) advantage for patients with metastatic castration-resistant prostate cancer (mCRPC) harboringContinue Reading
🛡️ We’re checking your connection to prevent automated abuse ⏳ Verifying your browser… Why am I seeing this verification? Having problems? Contact support ✓ Verification Complete This page will redirect in a moment… Read MoreContinue Reading
Skip to content